Decoy Therapeutics Ownership | Who Owns Decoy Therapeutics?
Decoy Therapeutics Ownership Summary
Decoy Therapeutics is owned by 0.81% institutional investors, 10.44% insiders, and 88.75% retail investors. Commonwealth equity services is the largest institutional shareholder, holding 6.02% of DCOY shares. Fidelity Extended Market Index is the top mutual fund, with 1.29% of its assets in Decoy Therapeutics shares.
DCOY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Decoy Therapeutics | 0.81% | 10.44% | 88.75% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Commonwealth equity services | 32.00K | 6.02% | $63.04K |
| Ubs group | 4.53K | 0.85% | $8.91K |
| Vanguard capital management | 4.03K | 0.76% | $7.95K |
| Jpmorgan chase | 80.00 | 0.01% | $170.00 |
| Advisory services network | - | - | - |
| Morgan stanley | - | - | - |
| Caitong asset management | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Commonwealth equity services | 32.00K | 0.00% | $63.04K |
| Jpmorgan chase | 80.00 | - | $170.00 |
| Ubs group | 4.53K | - | $8.91K |
| Advisory services network | - | - | - |
| Morgan stanley | - | - | - |
| Caitong asset management | - | - | - |
| Vanguard capital management | 4.03K | - | $7.95K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commonwealth equity services | 32.00K | 0.00% | 32.00K |
| Ubs group | 4.53K | - | 4.50K |
| Jpmorgan chase | 80.00 | - | 80.00 |
| Vanguard capital management | 4.03K | - | - |
| Morgan stanley | - | - | -1.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Advisory services network | - | - | -41.00 |
| Caitong asset management | - | - | -2.00 |
| Morgan stanley | - | - | -1.00 |
| Vanguard capital management | 4.03K | - | - |
| Jpmorgan chase | 80.00 | - | 80.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Commonwealth equity services | 32.00K | 0.00% | 32.00K | $63.04K |
| Jpmorgan chase | 80.00 | - | 80.00 | $170.00 |
Sold Out
| Holder | Change |
|---|---|
| Morgan stanley | -1.00 |
| Caitong asset management | -2.00 |
| Advisory services network | -41.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 4 | - | 4,317 | 168.30% | - | 886.94% | 2 | -50.00% | 2 | - |
| Mar 31, 2026 | 4 | - | 1,609 | - | - | - | 4 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 7.61K | 1.29% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 4.03K | 0.76% | - |
| Spartan Extended Market Index Pool F | 1.28K | 0.24% | - |
| Fidelity Series Total Market Index | 477.00 | 0.08% | - |
| Spartan Total Market Index Pool G | 169.00 | 0.03% | - |
| Spartan Total Market Index Pool A1 | 169.00 | 0.03% | - |
| Horizon Kinetics Medical ETF | 20.00 | 0.00% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 30, 2025 | HANISH ARNOLD C | - | Sell | $7.68 |
| Dec 30, 2025 | HANISH ARNOLD C | - | Sell | $9.60 |
| Nov 20, 2025 | HANISH ARNOLD C | - | Buy | $3.74K |
| Nov 20, 2025 | Rosenblum Mark J | Exec VP Finance, CFO | Buy | $16.00K |
| Jun 07, 2022 | Burleson Tess | Buy | $4.99K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2025 Q4 | 2 | 2 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q1 | - | - |
DCOY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools